HITOMICS LTD

**Company profile** HITOMICS LTD is a biotechnology research and development company (SIC 72110 — research and experimental development on biotechnology) registered at 141 Thornton Road, Girton, Cambridge CB3 0NE. The address is a residential road in the village of Girton, immediately north of Cambridge, a location commonly used by early-stage spinout founders and academics who base companies at home before securing lab space. The Cambridge CB3 postcode sits in the orbit of the Cambridge Biomedical Campus and university spinout ecosystem. The name "Hitomics" appears to fuse "hito" (Japanese/Greek root for "person" or "cell") with "omics," suggesting a genomics, proteomics, or single-cell analysis focus. **Contact channels and how they were verified** Searches for "Hitomics Ltd," "Hitomics Cambridge," and "Hitomics biotechnology" across business directories, academic spinout databases, BioWorld, Labiotech, Cambridge Network listings, and general open web sources returned no results for this company. No website, published email, phone number, LinkedIn company page, or biotech press mention was found. The company appears to be in a very early pre-commercial stage, potentially still assembling its scientific team and intellectual property before any public-facing presence. **How to approach this company** Early-stage Cambridge biotech spinouts are best approached through academic network channels. The director(s) listed on Companies House are likely affiliated with the University of Cambridge or a Cambridge research institute. A LinkedIn search for the director name combined with Cambridge and "omics" or "genomics" may yield a profile and connection opportunity. Venture networks such as Cambridge Enterprise or local angel groups active in life sciences may also have intelligence on this company's research direction. **Out of scope** No phone, email, website, or social media channels were found. No conference appearances, publications, or investor announcements are publicly linked to this company name. This record should be revisited in six to twelve months as the company progresses towards a commercial launch.